Vinca alkaloids and taxanes

Microtubule Dynamics - Tubulin Titans

• Core Concept: Arresting mitosis (M-phase) by disrupting microtubule function.

• Vinca Alkaloids (Vincristine, Vinblastine)

  • MOA: Bind β-tubulin, preventing polymerization into microtubules.
  • Toxicity:
    • Vincristine: Neurotoxicity (peripheral neuropathy). 📌 "Crisps the Nerves."
    • Vinblastine: Myelosuppression. 📌 "Blasts the Marrow."

• Taxanes (Paclitaxel, Docetaxel)

  • MOA: Hyperstabilize polymerized microtubules, preventing breakdown.
  • Toxicity: Myelosuppression, neuropathy.

⭐ Exam Favorite: Vincristine-induced neurotoxicity is a major dose-limiting side effect, manifesting as peripheral neuropathy (e.g., foot drop, paresthesias) and autonomic dysfunction (e.g., constipation).

Vinca Alkaloids - Arresting Assembly

• Mechanism of Action: Natural alkaloids from the periwinkle plant. They bind to β-tubulin, preventing its polymerization into microtubules. This disrupts the mitotic spindle, arresting the cell cycle in M-phase.
• Agents: Vincristine, Vinblastine, Vinorelbine.
  • 📌 Vinca alkaloids Arrest microtubule Assembly.
• Clinical Use:
  • Vincristine: Part of combination chemo for Acute Lymphoblastic Leukemia (ALL), Hodgkin & Non-Hodgkin lymphomas.
  • Vinblastine: Testicular cancer, Hodgkin lymphoma.
• Adverse Effects (Dose-Limiting):
  • Vincristine: Severe neurotoxicity (peripheral neuropathy, paresthesias).
  • Vinblastine: Potent myelosuppression.

⭐ Vincristine's signature toxicity is dose-limiting peripheral neuropathy ("stocking-glove" distribution), often presenting with loss of deep tendon reflexes like the Achilles reflex. Unlike Vinblastine, it has minimal myelosuppression.

• Resistance: Increased drug efflux via P-glycoprotein (MDR1 gene).

Taxanes - Frozen Scaffolding

• Mechanism: Hyperstabilize polymerized microtubules in the M phase, preventing mitotic spindle breakdown (anaphase cannot occur). This leads to apoptosis.
  • Binds to β-tubulin at a site distinct from vinca alkaloids.
  • 📌 Mnemonic: Paying your Taxes helps stabilize the economy.
• Agents: Paclitaxel, Docetaxel, Cabazitaxel.
• Clinical Use: Solid tumors, including breast, ovarian, lung, and prostate cancer.
• Adverse Effects:
  • Myelosuppression (neutropenia is dose-limiting).
  • Peripheral neuropathy (stocking-glove pattern).
  • Hypersensitivity reactions (especially with Paclitaxel).
  • Alopecia.

⭐ Exam Favorite: Paclitaxel can cause severe hypersensitivity reactions due to its solvent, Cremophor EL. Premedication with corticosteroids (e.g., dexamethasone) and H1/H2 blockers (e.g., diphenhydramine, ranitidine) is standard practice to prevent this.

Clinical Correlates - Toxicity & Resistance

• Vinca Alkaloids:

  • Vincristine: Dose-limiting neurotoxicity (peripheral neuropathy, areflexia, paresthesias). Minimal myelosuppression. 📌 "Vincristine cripples nerves."
  • Vinblastine/Vinorelbine: Dose-limiting myelosuppression. Less neurotoxic. 📌 "Vinblastine blasts marrow."

• Taxanes (Paclitaxel, Docetaxel):

  • Dose-limiting myelosuppression (neutropenia).
  • Peripheral neuropathy.
  • Hypersensitivity reactions (pre-medicate with steroids/antihistamines).
  • Docetaxel: notable for fluid retention.

• Resistance Mechanism:

  • Increased expression of P-glycoprotein (MDR1 gene), an efflux pump that removes the drug from the cell.

⭐ Exam Favorite: The key toxicity distinction: Vincristine's dose-limiting toxicity is neurotoxicity, whereas for Vinblastine and all Taxanes, it is myelosuppression.

• Vinca alkaloids and Taxanes are M-phase specific agents that target microtubules.
• Vincas (Vincristine, Vinblastine) prevent the polymerization of microtubules, leading to metaphase arrest.
• Taxanes (Paclitaxel, Docetaxel) prevent microtubule disassembly, effectively freezing the cell in mitosis.
• The major, dose-limiting toxicity of Vincristine is peripheral neuropathy.
• In contrast, Vinblastine is primarily known for causing myelosuppression.
• Paclitaxel's main side effects include myelosuppression, neuropathy, and hypersensitivity reactions.